|
TNKS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.99620000926626E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.2747000001705E-07 |
| Normal-vs-Stage2 |
1.40410000004643E-06 |
| Normal-vs-Stage3 |
3.17539999850069E-08 |
| Normal-vs-Stage4 |
1.83749999660421E-08 |
| Stage1-vs-Stage2 |
1.965020E-01 |
| Stage1-vs-Stage3 |
1.468410E-01 |
| Stage1-vs-Stage4 |
2.279500E-02 |
| Stage2-vs-Stage3 |
8.264200E-01 |
| Stage2-vs-Stage4 |
6.009600E-01 |
| Stage3-vs-Stage4 |
4.062800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.46049996727771E-09 |
| Normal-vs-AfricanAmerican |
3.733600E-02 |
| Normal-vs-Asian |
1.51857999999283E-05 |
| Caucasian-vs-AfricanAmerican |
1.241590E-01 |
| Caucasian-vs-Asian |
8.031800E-01 |
| AfricanAmerican-vs-Asian |
1.381400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.80040002298421E-09 |
| Normal-vs-Female |
7.83850000463104E-08 |
| Male-vs-Female |
2.467600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.23719999999927E-05 |
| Normal-vs-Age(41-60Yrs) |
4.62930005440398E-09 |
| Normal-vs-Age(61-80Yrs) |
3.67879999796372E-08 |
| Normal-vs-Age(81-100Yrs) |
6.035200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.134400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.886300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.897800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.374000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.892600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.473000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.188380E-01 |
| Classical-VS-Follicular |
3.023600E-02 |
| Classical-VS-Other |
1.884400E-01 |
| Classical-VS-Normal |
9.74800000053122E-07 |
| Tall-VS-Follicular |
9.099800E-01 |
| Tall-VS-Other |
5.710600E-01 |
| Tall-VS-Normal |
1.62117999999989E-05 |
| Follicular-VS-Other |
5.901800E-01 |
| Follicular-VS-Normal |
1.34530000028832E-07 |
| Other-VS-Normal |
3.359700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1239999759004E-09 |
| Normal-vs-N1 |
1.20619999999239E-06 |
| N0-vs-N1 |
8.658400E-01 |
|
|
